Skip to main content
Propanc Biopharma, Inc. logo

Propanc Biopharma, Inc. — Investor Relations & Filings

Ticker · PPCB ISIN · US74346N4043 LEI · 549300Q3HY827FNV8Y56 US Professional, scientific and technical activities
Filings indexed 412 across all filing types
Latest filing 2016-08-04 Capital/Financing Update
Country US United States of America
Listing US PPCB

About Propanc Biopharma, Inc.

https://www.propanc.com/

Propanc Biopharma, Inc. is a clinical-stage company developing cancer treatments focused on preventing tumor recurrence and metastasis. Its lead candidate, PRP, is a pancreatic proenzyme formulation designed to target and eradicate cancer stem cells. The therapeutic approach aims to suppress tumor progression by controlling cancer cell migration, inhibiting the formation of tumor blood vessels, and inducing cell death. The company's primary focus is on developing long-term therapies for patients with solid tumors, such as pancreatic cancer.

Recent filings

Filing Released Lang Actions
424B3
Capital/Financing Update Classification · 95% confidence The document is a Prospectus Supplement No. 2 filed pursuant to Rule 424(b)(3) related to a securities offering, specifically for 171,000,000 shares of common stock. It references a Current Report on Form 8-K filed on August 4, 2016, which details a material definitive agreement involving warrants and debentures. The document is primarily a prospectus supplement and includes detailed terms of securities purchase agreements and warrants. This type of filing is related to capital raising activities and financing updates rather than a full annual or quarterly report, audit, or management discussion. The presence of a prospectus supplement and detailed securities issuance terms aligns with a Capital/Financing Update filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2016-08-04 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content describes a material definitive agreement related to financing terms, including a Letter Agreement and Warrants issued to a purchaser. It details changes to a securities purchase agreement and issuance of warrants, which are capital raising activities. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document is not a proxy, governance, or legal proceeding report. The primary focus is on financing terms and capital structure changes. Therefore, the document fits best under Capital/Financing Update (CAP). The document length and detail support this classification with high confidence.
2016-08-04 English
424B3
Capital/Financing Update Classification · 100% confidence The document is a Form 424B3 Prospectus Supplement filed pursuant to Rule 424(b)(3) related to a securities offering. It updates and supplements a prior prospectus and includes details about a securities purchase agreement, warrant exercise, and related financing terms. The document references filings such as Form 8-K and Form 10-Q but is itself a prospectus supplement primarily concerning capital raising and financing activities. It is not a financial report, earnings release, or management discussion. The content focuses on the terms of a financing transaction, warrant repricing, and issuance of shares. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2016-07-06 English
424B3
Capital/Financing Update Classification · 95% confidence The document is a Form 424B3 Prospectus Supplement filed pursuant to Rule 424(b)(3) related to a securities offering. It includes detailed information about a securities purchase agreement, warrant exercise, and related financing terms. The document references filings such as Form 8-K and Form 10-Q but is itself a prospectus supplement updating the original prospectus for a stock offering. The content focuses on capital raising activities, terms of warrants, and securities issuance. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. The document length is substantial and contains detailed transaction terms, not merely an announcement or a brief summary, confirming it is a substantive financing update rather than a simple announcement or regulatory filing.
2016-07-06 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a material definitive agreement related to financing activities, specifically a Letter Agreement modifying terms of a securities purchase agreement involving debentures and warrants. It also details unregistered sales of equity securities and includes a press release about these transactions. There are no financial statements or comprehensive financial data typical of annual or quarterly reports. The focus is on financing and capital structure changes. Therefore, this document fits best under the category of Capital/Financing Update (CAP). The document length (6574 characters) and detailed description of financing terms support this classification with high confidence.
2016-07-05 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content describes a settlement and repayment of a secured convertible promissory note, which relates to financing activities. There is no detailed financial data or comprehensive report content, so it is not an Annual Report, Interim Report, or Earnings Release. The document is not a certification or legal proceeding update. The key event is a financing-related settlement and repayment, fitting the Capital/Financing Update category. The document length is short and focused on a financing event, confirming classification as CAP.
2016-05-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.